1. Gupta RS, et al. The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States. Pediatrics 142, (2018).
2. Sicherer SH, Sampson HA. Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol 141, 41-58 (2018).
3. Flom JD, Sicherer SH. Epidemiology of Cow's Milk Allergy. Nutrients 11, (2019).
4. Lifschitz C, Szajewska H. Cow's milk allergy: evidence-based diagnosis and management for the practitioner. Eur J Pediatr 174, 141-150 (2015).
5. Nurmatov U, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy 72, 1133-1147 (2017).
6. Globinska A, et al. Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens. Ann Allergy Asthma Immunol 121, 306-312 (2018).
7. Satitsuksanoa P, Jansen K, Globinska A, van de Veen W, Akdis M. Regulatory Immune Mechanisms in Tolerance to Food Allergy. Front Immunol 9, 2939 (2018).
8. Boyce JA, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res 31, 61-75 (2011).
9. Satitsuksanoa P, Daanje M, Akdis M, Boyd SD, van de Veen W. Biology and dynamics of B cells in the context of IgE-mediated food allergy. Allergy, (2020).
10. Satitsuksanoa P, van de Veen W, Akdis M. B cells in food allergy. J Allergy Clin Immunol 147, 49-51 (2021).
11. Muraro A, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 69, 1008-1025 (2014).
12. Jimenez-Saiz R, et al. IgG1(+) B-cell immunity predates IgE responses in epicutaneous sensitization to foods. Allergy 74, 165-175 (2019).
13. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 199, 1679-1688 (2004).
14. Hoh RA, et al. Origins and clonal convergence of gastrointestinal IgE(+) B cells in human peanut allergy. Sci Immunol 5, (2020).
15. Croote D, Darmanis S, Nadeau KC, Quake SR. High-affinity allergen-specific human antibodies cloned from single IgE B cell transcriptomes. Science 362, 1306-1309 (2018).
16. Heeringa JJ, et al. IgE-expressing memory B cells and plasmablasts are increased in blood of children with asthma, food allergy, and atopic dermatitis. Allergy 73, 1331-1336 (2018).
17. Gupta J, et al. Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry. J Allergy Clin Immunol 138, 676-699 (2016).
18. Shan M, et al. Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44. Immunity 49, 709-724 e708 (2018).
19. Wal JM. Cow's milk proteins/allergens. Ann Allergy Asthma Immunol 89, 3-10 (2002).
20. Wal JM. Bovine milk allergenicity. Ann Allergy Asthma Immunol 93, S2-11 (2004).
21. Hoh RA, et al. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin Immunol 137, 157-167 (2016).
22. van de Veen W, et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 131, 1204-1212 (2013).
23. Boonpiyathad T, et al. Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy. J Allergy Clin Immunol 143, 1077-1086 e1010 (2019).
24. Okamoto S, et al. Predictive value of IgE/IgG4 antibody ratio in children with egg allergy. Allergy Asthma Clin Immunol 8, 9 (2012).
25. Cerecedo I, et al. Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol 122, 589-594 (2008).
26. Boonpiyathad T, et al. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers. Allergy 72, 407-415 (2017).
27. Caubet JC, et al. Natural tolerance development in cow's milk allergic children: IgE and IgG4 epitope binding. Allergy 72, 1677-1685 (2017).
28. Ranasinghe R, Eri R. Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer. Medicina (Kaunas) 54, (2018).
29. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 116, 608-613 (2005).
30. Jutel M, et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33, 1205-1214 (2003).
31. Cevhertas L, et al. IL-10 induces IgG4 production in NOD-scid Il2rgamma(null) mice humanized by engraftment of peripheral blood mononuclear cells. Allergy, (2021).
32. Suzuki M, et al. Inhibition of allergic responses by CD40 gene silencing. Allergy 64, 387-397 (2009).
33. Kim JH, et al. Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline. J Hum Genet 56, 652-659 (2011).
34. Ubel C, et al. The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast cell-driven immune responses in the setting of allergic asthma. J Allergy Clin Immunol 133, 198-206 e191-199 (2014).
35. Eder W, et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 113, 482-488 (2004).
36. Ayuso P, et al. Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs. Pharmacogenomics 14, 1871-1878 (2013).
37. Lawrence MG, et al. Elevated IgE and atopy in patients treated for early-onset ADA-SCID. J Allergy Clin Immunol 132, 1444-1446 (2013).
38. Sicherer SH, Bollinger ME, Hershfield MS, Sampson HA, Lederman HM. Food allergy in a patient with adenosine deaminase deficiency undergoing enzyme replacement with polyethylene glycol-modified adenosine deaminase. J Allergy Clin Immunol 101, 561-562 (1998).
39. Yeon SM, et al. IL-7 plays a critical role for the homeostasis of allergen-specific memory CD4 T cells in the lung and airways. Sci Rep 7, 11155 (2017).
40. Meyts I, et al. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 177, 6460-6470 (2006).
41. Sanders NL, Mishra A. Role of interleukin-18 in the pathophysiology of allergic diseases. Cytokine Growth Factor Rev 32, 31-39 (2016).
42. Peng J, Yang XO, Chang SH, Yang J, Dong C. IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation. Cell Res 20, 62-71 (2010).
43. Campbell JD, Gangur V, Simons FE, HayGlass KT. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J 18, 329-331 (2004).
44. Ohta T, et al. Crucial roles of XCR1-expressing dendritic cells and the XCR1-XCL1 chemokine axis in intestinal immune homeostasis. Sci Rep 6, 23505 (2016).
45. Otero K, et al. Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood 116, 2942-2949 (2010).
46. Tschopp CM, et al. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood 108, 2290-2299 (2006).
47. Weissler KA, Frischmeyer-Guerrerio PA. Genetic evidence for the role of transforming growth factor-beta in atopic phenotypes. Curr Opin Immunol 60, 54-62 (2019).
48. Ibrahim S, et al. PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway. Cancer Biol Ther 19, 222-229 (2018).
49. Honjo A, et al. Pharmacologic inhibition of Notch signaling suppresses food antigen-induced mucosal mast cell hyperplasia. J Allergy Clin Immunol 139, 987-996 e910 (2017).
50. Lechner M, et al. Notch2-mediated plasticity between marginal zone and follicular B cells. Nat Commun 12, 1111 (2021).
51. Iwahashi S, et al. Notch2 regulates the development of marginal zone B cells through Fos. Biochem Biophys Res Commun 418, 701-707 (2012).
52. van Keimpema M, et al. The forkhead transcription factor FOXP1 represses human plasma cell differentiation. Blood 126, 2098-2109 (2015).
53. Berglund LJ, et al. IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts. Blood 122, 3940-3950 (2013).
54. Ward-Kavanagh LK, Lin WW, Sedy JR, Ware CF. The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses. Immunity 44, 1005-1019 (2016).
55. Browne EP. Regulation of B-cell responses by Toll-like receptors. Immunology 136, 370-379 (2012).
56. Clark EA, Giltiay NV. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity. Front Immunol 9, 2235 (2018).
57. Orgel KA, et al. Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2. J Allergy Clin Immunol 139, 366-369 e362 (2017).
58. Avery DT, et al. Germline-activating mutations in PIK3CD compromise B cell development and function. J Exp Med 215, 2073-2095 (2018).
59. Ogasawara T, et al. Allergic TH2 Response Governed by B-Cell Lymphoma 6 Function in Naturally Occurring Memory Phenotype CD4(+) T Cells. Front Immunol 9, 750 (2018).
60. Wei Z, et al. Pathogenic CARD11 mutations affect B cell development and differentiation through a noncanonical pathway. Sci Immunol 4, (2019).
61. Ma CA, et al. Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet 49, 1192-1201 (2017).
62. Buchbinder D, et al. Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation. J Allergy Clin Immunol 136, 819-821 e811 (2015).
63. Boonpiyathad T, Pradubpongsa P, Mitthamsiri W, Satitsuksanoa P, Jacquet A, Sangasapaviliya A. Allergen-specific immunotherapy boosts allergen-specific IgD production in house dust mite-sensitized asthmatic patients. Allergy 75, 1457-1460 (2020).
64. Blumchen K, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 126, 83-91 e81 (2010).
65. Reth M. B cell antigen receptors. Curr Opin Immunol 6, 3-8 (1994).
66. Moon HG, et al. Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma. Allergy 75, 357-369 (2020).
67. Giannetti M, Schroeder HA, Zalewski A, Gonsalves N, Bryce PJ. Dysregulation of the Wnt pathway in adult eosinophilic esophagitis. Dis Esophagus 28, 705-710 (2015).
68. Brooks AM, Bates ME, Vrtis RF, Jarjour NN, Bertics PJ, Sedgwick JB. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. Am J Respir Cell Mol Biol 35, 503-511 (2006).
69. Bednash JS, Johns F, Patel N, Smail TR, Londino JD, Mallampalli RK. The deubiquitinase STAMBP modulates cytokine secretion through the NLRP3 inflammasome. Cell Signal 79, 109859 (2021).
70. Bednash JS, et al. Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity. Nat Commun 8, 15203 (2017).
71. Remuzgo-Martinez S, et al. Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis. Sci Rep 6, 29713 (2016).
72. Naveed SU, et al. Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma Severity. Am J Respir Crit Care Med 195, 1000-1009 (2017).
73. Agrawal DK, Hopfenspirger MT, Chavez J, Talmadge JE. Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model. Int Immunopharmacol 1, 2081-2089 (2001).
74. Qi X, et al. Critical role of caspase-8-mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis. Mucosal Immunol 10, 128-138 (2017).
75. Weckmann M, et al. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease. Nature medicine 13, 1308-1315 (2007).
76. Choi GS, et al. Vascular endothelial growth factor in allergen-induced nasal inflammation. Clin Exp Allergy 39, 655-661 (2009).
77. Szalai C, et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 108, 375-381 (2001).
78. Lamkhioued B, et al. Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med 162, 723-732 (2000).
79. Kuo CS, et al. Contribution of airway eosinophils in airway wall remodeling in asthma: Role of MMP-10 and MET. Allergy 74, 1102-1112 (2019).
80. Murota H, et al. Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis. J Allergy Clin Immunol 130, 671-682 e674 (2012).
81. Begin P, et al. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol 10, 1 (2014).
82. Begin P, et al. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol 10, 7 (2014).
83. Andorf S, et al. A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals. EClinicalMedicine 7, 27-38 (2019).
84. Kwakkenbos MJ, et al. Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nature medicine 16, 123-128 (2010).
85. Kwakkenbos MJ, van Helden PM, Beaumont T, Spits H. Stable long-term cultures of self-renewing B cells and their applications. Immunol Rev 270, 65-77 (2016).
86. van de Veen W, et al. A novel proangiogenic B cell subset is increased in cancer and chronic inflammation. Sci Adv 6, eaaz3559 (2020).